Arbeitsgruppe Kopf-Hals-Tumoren - Studien
| AIO-assoziierte-Studie | zur Studie | |||
| AIO-KHT-0121/ass: First-line treatment of locally advanced HNSCC with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+ T cell infiltration (CheckRad-CD8) | ||||
| ---Rekrutierung beendet--- | ||||
| operable Kopf-Hals Tumoren |
||||
| AIO-assoziierte-Studie | www.clinicaltrials.gov | zur Studie | ||
| AIO-KHT-0220/ass: Window of opportunity study of preoperative immunotherapy with atezolizumab (Tecentriq®) or FAP-interleukin 2v (IL2v) (RO6874281) in local squamous cell carcinoma of the head and neck – an imCORE Study (PIONEER) | ||||
| ---in Rekrutierung--- | ||||
| LETZTE AKTUALISIERUNG DIESER SEITE AM: 05.11.2021 |